Friday, November 22, 2024
HomeTagsBA3021

BA3021

BioAtla Announces Clinical Collaboration with Bristol Myers Squibb for Treatment of Solid Tumors

BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, announced that it has entered into...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics